Archived explainer. For the current picture see today's TEM page.
Why Is TEMPUS AI INC A (TEM) Stock Up Today?
By the Top Tier Newswire AI Desk · September 24, 2026 at 3:52 PM ET · reviewed against 3 wire stories
TEMPUS AI INC A (TEM) is up +7.02% in the latest session. Our newswire has captured 3 stories on TEM across 2 sources in the last 36 hours, with AI sentiment reading bullish (avg 59/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Tempus AI Inc. (TEM) surged 7.02% to $81.97 in a volatile session driven by a combination of market sentiment, a recent data partnership extension, and mixed analyst coverage. The stock opened lower but reversed sharply, reaching an intraday high of $82.30. The move came amid Goldman Sachs’ initiation of a Neutral rating with a $75 price target, as well as broader optimism around the company’s data and pricing growth.
What Happened
The stock’s sharp rebound followed a 30% year-to-date rebound, though insiders including the Chief Accounting Officer, CEO Eric Lefkofsky, and EVP Andrew Polovin sold shares on September 17. The CEO highlighted strong demand for genomic profiling and data-licensing growth in recent remarks, while Tempus AI extended its data partnership with Recursion through 2029. This deal replaces potential $84 million in fees with $42 million in committed payments and includes a license to Recursion’s RNA model. The stock’s intraday move was also supported by a large call options print worth $489,000, indicating bullish positioning.
What The Data Shows
Over the last eight sessions, the stock has gained 15.1%, rising from $66.76 to $76.87. The current session saw volume of 7.5 million shares, 1.1 times the 3-month average, with a high of $82.30 at the close. The stock is trading near its 52-week high of $104.32 and has printed 28 fresh 52-week highs this session. Despite a market cap of $14.1 billion, the company remains unprofitable, with a trailing 12-month net margin of -17.8% and earnings per share of -1.43. Its beta of 3.72 reflects high volatility relative to the broader market.
What To Watch
The stock is set to face continued scrutiny as Goldman Sachs’ $75 price target contrasts with the current rally. Coverage breadth and any additional analyst commentary will be key to monitoring the stock’s momentum.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
TEM · today's session (5-min) · +6.42% vs prior close · updated 8:44 PM ETAI sentiment, last 36h · averaged over 3 stories · 59/100 bullish
The headlines behind the move
Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
12h agoThe Motley FoolNEUTRAL 54General
Tempus AI Chief Accounting Officer Sells $529,650 of Stock
Sale follows 30% rebound in the stock year to date.
2d agoYahoo FinanceBULLISH 56Analyst
Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test
Goldman Sachs’ Neutral initiation of Tempus AI, Inc. (NASDAQ:TEM) on September 21 puts the company’s fastest-growing businesses under different tests: diagnostics offers visible near-term growth, while the data and applications segment faces renewal risk as several major contracts approach extensions over the next two years. The timing is notable because Tempus AI, Inc. (NASDAQ:TEM) announced […]
3d agoYahoo FinanceBULLISH 67Product/PR
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion
Tempus AI (NASDAQ:TEM) Founder and CEO Eric Lefkofsky said the company’s second-quarter performance was supported by continued demand for comprehensive genomic profiling and growth in its data-licensing business. Speaking at Morgan Stanley’s Global Healthcare Conference, Lefkofsky said the diagnost
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →